ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

EPRX Eupraxia Pharmaceuticals Inc

3.72
0.03 (0.81%)
02 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Eupraxia Pharmaceuticals Inc EPRX Toronto Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.03 0.81% 3.72 14:59:58
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
3.70 3.69 3.80 3.72 3.69
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
02/5/202406:00PRNUSEupraxia Pharmaceuticals Announces Gastrointestinal Clinical..
11/4/202406:00PRNUSEupraxia Pharmaceuticals Announces Upcoming Presentations at..
08/4/202406:00PRNCAEupraxia Pharmaceuticals To Present at Bloom Burton & Co...
05/4/202406:00PRNUSEupraxia Pharmaceuticals Begins Trading on Nasdaq Today
03/4/202416:00PRNCAEupraxia Pharmaceuticals to Begin Trading on Nasdaq on April..
01/4/202416:01PRNCAEupraxia Pharmaceuticals Reports Fourth Quarter and 2023..
15/3/202407:26GLOBEEupraxia Pharmaceuticals Announces Closing of Overnight..
12/3/202408:41PRNCAL'Organisme canadien de réglementation des investissements..
12/3/202408:39PRNCACanadian Investment Regulatory Organization Trade Resumption..
12/3/202408:31GLOBEEupraxia Pharmaceuticals Announces Pricing of Overnight..
11/3/202415:08GLOBEEupraxia Pharmaceuticals Announces Overnight Marketed..
11/3/202415:06PRNCASuspension de la négociation par l'Organisme canadien de..
11/3/202415:04PRNCACanadian Investment Regulatory Organization Trading Halt -..
05/2/202416:00PRNCAEupraxia Pharmaceuticals Announces Updated Positive Clinical..
01/2/202406:00PRNCAEupraxia Pharmaceuticals Initiates Phase 3 Development..
30/1/202406:00PRNCAEupraxia Pharmaceuticals Announces Positive Data from MRI..
08/1/202417:44PRNCAEupraxia Pharmaceuticals Announces Filing of Preliminary..
12/12/202306:00PRNCAEupraxia Pharmaceuticals Announces Positive Clinical Data in..
11/12/202306:00PRNCAEupraxia Pharmaceuticals Announces Clinical and Corporate..
14/11/202316:01PRNCAEupraxia Pharmaceuticals Reports Third Quarter 2023..
01/11/202306:00PRNCAEupraxia Pharmaceuticals to Present at the 2023 Annual..
11/10/202306:00PRNCAEupraxia Pharmaceuticals Announces Initiation of Second..
11/9/202314:32PRNCAEupraxia Pharmaceuticals to Present at the H.C. Wainwright..
07/9/202316:00PRNCAEupraxia Pharmaceuticals Announces Change of Auditor
06/9/202316:00PRNCAEupraxia Pharmaceuticals Announces Presentation at PAINWeek..
18/8/202318:20PRNCAEupraxia Pharmaceuticals Announces Closing of Non-Brokered..
11/8/202316:00PRNCAEupraxia Pharmaceuticals Reports Second Quarter 2023..
04/8/202306:00PRNCAEupraxia Pharmaceuticals Announces a Non-Brokered Private..
26/6/202306:00PRNUSEupraxia Pharmaceuticals Reports Positive Topline Data in..
15/6/202317:42PRNCAEupraxia Pharmaceuticals Announces Filing of Preliminary..
13/6/202310:04DJNEupraxia Shares Climb After FDA Fast-Track Designation for..
13/6/202306:43DJNEupraxia Pharmaceuticals Gets FDA Fast-Track Designation for..
13/6/202306:00PRNCAEupraxia Pharmaceuticals Receives U.S. FDA Fast Track..
08/6/202306:00PRNCAEupraxia Pharmaceuticals Doses First Patient in Phase 1b/2a..
25/5/202306:00PRNCAEupraxia Pharmaceuticals Announces Last Patient Last Visit..
18/5/202306:00PRNCAEupraxia Pharmaceuticals Announces Appointment of Dr. Mark..
11/5/202306:00PRNCAEupraxia Pharmaceuticals Reports First Quarter 2023..

Su Consulta Reciente

Delayed Upgrade Clock